Watch Now:Â Calidi Biotherapeutics and City of Hope announce first patients dosed in a Phase 1 clinical trial
→
Company
Company
About
History
Team
Careers
Medical &Â Scientific Advisors
Board of Advisors
Our Science
How It Works
Novel Platform
Publications
Medical &Â Scientific Advisors
Board of Advisors
Our Science
Pipeline
Newsroom
Investors
English
Contact
Publication
Phase 1 Study of Multiple Intracerebral Doses of a Neural Stem Cell-based Oncolytic Virotherapy for Treatment of Recurrent High-grade Gliomas
ASCO Annual Meeting 2024
June 1, 2024
A talented, seasoned group of world-class executives, doctors, and scientists producing revolutionary work.
Learn more
A talented, seasoned group of world-class executives, doctors, and scientists producing revolutionary work.
Learn more